Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001788908-21-000002

Options or other derivatives

  • Chief Financial Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

LINTAL ELLEN M · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-11-30 Grant or award : show line 1 in the form Options +100,000 100,000 D
Loading xslF345X03/primary_doc.xml…